Trial Profile
NCRN074 - INDUSTRY STUDY.
Status:
Suspended
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2011
Price :
$35
*
At a glance
- Drugs Bosutinib (Primary) ; Letrozole (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 23 Mar 2011 Status changed from not yet recruiting to suspended as reported by United Kingdom Clinical Research Network record.
- 29 Jan 2010 Status changed from planning to not yet recruiting as reported by United Kingdom Clinical Research Network record.
- 23 Jun 2009 New trial record